Author:
Peng Jianhong,Li Weihao,Fan Wenhua,Zhou Wenhao,Zhu Ying,Li Xueying,Pan Zhizhong,Lin Xiaoping,Lin Junzhong
Funder
National Natural Science Foundation of China
Natural Science Foundation of Guangdong Province
Subject
Pharmacology (medical),Pharmacology
Reference23 articles.
1. Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial;Alberts;Jama,2012
2. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial;Andre;J. Clin. Oncol.,2009
3. Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial;Andre;J. Clin. Oncol.,2018
4. Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy;Auclin;Ann. Oncol.,2017
5. Nerves and neurotropic carcinomas;Batsakis;Ann. Otol. Rhinol. Laryngol.,1985
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献